Alabama
Birmingham; Global Clinical Trial Link, LLC
Study of Sativex® for Pain Relief in Patients With Advanced Malignancy. (SPRAY study)
Arizona
Casa Grande; Desert Oasis Cancer Center
Study of Sativex® for Pain Relief in Patients With Advanced Malignancy. (SPRAY study)
California
Duarte; City of Hope
Reducing Barriers to Pain and Fatigue Management
Fountain Valley; Pacific Coast Hematology/Oncology Medical Group, Inc.
Study of Sativex® for Pain Relief in Patients With Advanced Malignancy. (SPRAY study)
Gilroy; Office of Dr. Ronald Yanagihara
Study of Sativex® for Pain Relief in Patients With Advanced Malignancy. (SPRAY study)
Loma Linda; Center for Pain Management
Study of Sativex® for Pain Relief in Patients With Advanced Malignancy. (SPRAY study)
Florida
Sarasota; Lovelace Scientific Resources - Sarasota
Phase III Study to Evaluate the Safety and Efficacy of an investigational medication for Breakthrough Cancer Pain
Tampa; University of Southern Florida
Study of Sativex® for Pain Relief in Patients With Advanced Malignancy. (SPRAY study)
West Palm Beach; Palm Beach Research Center
Do you have CANCER and experience UNEXPECTED PAIN?
Georgia
Decatur; Dekalb Pain Center
Study of Sativex® for Pain Relief in Patients With Advanced Malignancy. (SPRAY study)
Stockbridge; Center of Hope for Cancer and Blood Disorders
Study of Sativex® for Pain Relief in Patients With Advanced Malignancy. (SPRAY study)
Louisiana
New Orleans; Louisiana Research Associates
Study of Sativex® for Pain Relief in Patients With Advanced Malignancy. (SPRAY study)
Maryland
Hagerstown; Research Center
Study of Sativex® for Pain Relief in Patients With Advanced Malignancy. (SPRAY study)
Mississippi
Hattiesburg; Forrest General Hospital
Study of Sativex® for Pain Relief in Patients With Advanced Malignancy. (SPRAY study)
Hattiesburg; Forrest General Hospital
Study of Sativex® for Pain Relief in Patients With Advanced Malignancy. (SPRAY study)
Missouri
Jefferson City; Capital Comprehensive Cancer Care Clinic
Study of Sativex® for Pain Relief in Patients With Advanced Malignancy. (SPRAY study)
St. Louis; A & A Pain Institute
Study of Sativex® for Pain Relief in Patients With Advanced Malignancy. (SPRAY study)
Montana
Great Falls; Research Center
Study of Sativex® for Pain Relief in Patients With Advanced Malignancy. (SPRAY study)
New Jersey
Englewood; Biomedical Research Alliance of New York
Clinical trial to test a study drug in chronic malignant tumor-related pain.
Ridgewood; Neurology Group of Bergen County, P.A.
Research study of an experimental pain medication for patients with pain related to cancer.
New York
New York; Biomedical Research Aliance of New York
Cancer Pain
New York; Biomedical Research Alliance of New York
Cancer Pain
North Carolina
Flat Rock; Four Seasons Hospice & Pallative Care
Study of Sativex® for Pain Relief in Patients With Advanced Malignancy. (SPRAY study)
Winston-Salem; Center for Clinical Research
Study of Sativex® for Pain Relief in Patients With Advanced Malignancy. (SPRAY study)
Ohio
Canton; Gabrail Cancer Center
Study of Sativex® for Pain Relief in Patients With Advanced Malignancy. (SPRAY study)
Dover; Gabrail Cancer Center
Study of Sativex® for Pain Relief in Patients With Advanced Malignancy. (SPRAY study)
Oklahoma
Oklahoma City; Oklahoma Gynecologic Oncology
Study of Sativex® for Pain Relief in Patients With Advanced Malignancy. (SPRAY study)
South Carolina
Sumter; Office of Billy Clowney
Study of Sativex® for Pain Relief in Patients With Advanced Malignancy. (SPRAY study)
Texas
Austin; Lone Star Oncology
Study of Sativex® for Pain Relief in Patients With Advanced Malignancy. (SPRAY study)
Utah
Salt Lake City; Lifetree Clinical Research
A dose escalation study of NKTR-118 in patients with opioid-induced constipation (OIC).
